entertainment -WSS

entertainment

author：fashion 2025-08-25 05:56:58 - browse：9662

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Emergent cuts jobs, executive role in business shake

knowledge

WSS

HIV vaccine remains elusive. Immunologists keep trying new ideas

NIH trials fail to test meaningful long Covid therapies, experts say

Criminal prosecution for violating HIPAA: an emerging threat

Data integrity in scientific journals requires "effort" by publishers, institutions

NVIDIA and Google execs on the future of AI and drug discovery

Man killed during FBI raid in connection with threats against Biden, other officials

hotspot

entertainment

focus

Novavax promises a turnaround & Lilly roils the obesity market

Why failed clinical trials don’t always spell doom for a new drug

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

American woman, child freed after being kidnapped in Haiti last month

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Moonlake's readout produced a cash windfall. Risks remain

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Sports medicine is finally prioritizing gender equality

What to know about Virgin Galactic's 1st mission taking paying customers to space

focus

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Methadone doses haven’t kept up in the age of fentanyl

Addiction experts warn against a second 'war on drugs'

Solving academic medical centers' existential crisis

Wegovy’s successful heart trial raises vital question about weight loss

Case highlights the risks of experimental stem cell therapy

entertainment

knowledge

focus

explore